Table 6 The results of Cmax, AUC0 − t and AUC0−∞ bidirectional one-sided T-test and [1–2α] CI method (BES, N = 12).

From: Investigation into the pharmacodynamics and pharmacokinetics of recombinant human interferon alfa-2b vaginal suppository following process optimization in chinese rhesus macaque

Parameter

t-value

P-value

Geometric mean and ratio (N = 12)

Individual variability %CV of subjects

90% CI

Compared to the lower limit tL

Compared to the high limit tH

Compared to the lower limit PL

Compared to the high limit PH

Sample R

Sample S

(S/R) %

Cmax (np/ml)

3.33

-4.35

0.0038

0.0007

1.42

1.38

97.09

14.30

87.39%~107.87%

AUC0 − t (ng∙h/ml)

0.72

-12.07

0.2454

0.0000

12.32

10.11

82.02

8.56

76.99%~87.38%

AUC0−∞ (ng∙h/ml)

0.75

-12.28

0.2340

0.0000

12.47

10.24

82.09

8.40

77.15%~87.35%